PTK2 and breast carcinoma: Having established a role of SMARCE1 in regulating metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway, we sought to examine the clinical relevance of this finding by examining the relationship between the SMARCE1 and PTK2 expression and the clinical outcomes of breast cancer patients.